Sibeprenlimab 400 mg
417-201-00007
Phase 3 small_molecule active
Quick answer
Sibeprenlimab 400 mg for Immunoglobulin A Nephropathy is a Phase 3 program (small_molecule) at Otsuka Beijing Research Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Otsuka Beijing Research Institute
- Indication
- Immunoglobulin A Nephropathy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active